Properties:
- it is the therapeutic solution recommended by the European Urolithiasis Guidelines in the prevention of calcification of urinary catheters and the treatment of infectious renal lithiasis (struvite, apatite, brushitis) ensuring controlled urinary acidification (pH 5.8 - 6.2).
Directions:
The recommended daily dose of Struviren is 1 tablet. 500 mg 2 times a day. In some cases, the daily dose of Struviren can vary between 500 mg and 3000 mg. The optimal dose of Struviren is the dose that manages to adjust and maintain the urinary pH at values between 5.8 and 6.2. The daily dose should be taken in two equal doses (morning and evening). In order to quickly achieve urinary acidification, it is recommended to start treatment with 2 tablets a day.
Active ingredients:
Each Struviren tablet contains 500 mg of L-methionine as a physiological action ingredient.
Contraindications:
It is contraindicated in patients with renal or hepatic dysfunction, distal renal tubular acidosis, hyperuricemia, hyperuricosuria, uric lithiasis, cystine lithiasis.
Co-administration of L-methionine with ampicillin, sulfonamide or nitrofurantoin antibiotics may lead to prolonged plasma half-life and potentiate their effect, as these weak acids tend to be reabsorbed by urinary acidification.
There are no studies conducted for the administration of L-methionine in children. L-methionine should not be administered to children under 12 years of age.
Presentation:
60 tablets